Tele: 561.316.3330
Breaking Medical Device News

Tuesday, September 21, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFACT.MRSales of Scoring Balloon Catheter for Dialysis is Expected to Gain Steadfast Traction, Procuring an Annual Growth of more than US$ 200 Mn | Fact.MR

Sales of Scoring Balloon Catheter for Dialysis is Expected to Gain Steadfast Traction, Procuring an Annual Growth of more than US$ 200 Mn | Fact.MR

The growing prevalence of peripheral vascular and coronary artery diseases has fuelled demand for scoring balloon catheter devices in the healthcare sector. Moreover, increasing demand for medical devices equipped with enhanced technology is projected to impact the global market growth of scoring balloon catheter positively. According to a recently published report, the global scoring balloon catheter market will reflect sluggish CAGR growth over the forecast period, 2017 – 2022.

For detailed insights on enhancing your product footprint, request a sample here

https://www.factmr.com/connectus/sample?flag=S&rep_id=148

Factors Propelling Global Market Growth

The increasing prevalence of coronary artery diseases has led to an upsurge in demand for scoring balloon catheter devices in the healthcare sector. Healthcare manufacturers prefer scoring balloon catheter devices over conventional devices for the treatment of coronary artery diseases attributed to limitations such as uncontrolled dissections including bailout stenting and insufficient luminal expansion. Moreover, healthcare professionals prefer using scoring balloon catheter devices over conventional catheter devices for the treatment of peripheral vascular diseases. The fibrocalcific lesion is resistant to dilation through conventional balloon catheter devices attributed to inadequate luminal expansion. Due to these factors, manufacturers are adopting scoring technology for the production of scoring balloon catheter devices in the healthcare sector. These factors are likely to contribute towards the global market growth of scoring balloon catheter positively.

On the other hand, growing risks regarding artery collapse during the catheterization treatment are projected to influence demand for scoring balloon catheter devices negatively. Moreover, increasing risks of infection due to the treatment of catheterization is projected to pose significant challenges for scoring balloon catheter devices in the global market by 2022 – end. These factors are expected to inhibit the global market growth of scoring balloon catheter devices during the projected period.

For comprehensive insights on this market adoption, ask an analyst here 

 https://www.factmr.com/connectus/sample?flag=AE&rep_id=148

Market Segmentation 

Global Scoring Balloon Catheter Market Analysis and Forecast By Indication

  • Coronary Artery Disease Scoring Balloon Catheter
  • Peripheral Vascular Disease Scoring Balloon Catheter

Global Scoring Balloon Catheter Market Analysis and Forecast By End User 

  • Hospitals Scoring Balloon Catheter
  • Ambulatory Surgical Centers Scoring Balloon Catheter
  • Cardiac Catheterization Laboratories Scoring Balloon Catheter

Global Scoring Balloon Catheter Market Analysis and Forecast By Raw Material 

  • Polyurethane Scoring Balloon Catheter
  • Nylon to Represent a Leading Market

Global Scoring Balloon Catheter Market Analysis and Forecast By Region

  • North America
  • Europe
  • Asia-Pacific (APAC)
  • Japan
  • Latin America (LATAM)
  • MENA

Cardiac catheterization laboratories are projected to register a relatively high CAGR among other end users in the global market of scoring balloon catheter through 2022. In revenue terms, hospitals will witness relatively high growth in the global market by 2022–end. Hospitals in Europe are projected to generate significant revenue globally throughout 2022.

In terms of disease indications, coronary artery disease is projected to represent a relatively high growth in revenue terms in the global market of scoring balloon catheter devices. This segment will witness around US$ 40 Mn in the global market in 2017. The peripheral vascular disease segment is projected to register significant growth after the coronary artery disease segment.

Full Access of this Exclusive Report is Available at- 

https://www.factmr.com/checkout/148/S

Nylon among various raw materials is projected to register a relatively high growth in revenue terms throughout 2022. This segment will represent US$ 30 Mn by the end of 2017. Among other regions, North America will witness a major market for the nylon segment globally. Polyurethane is projected to reflect a relatively high CAGR in the global market by 2022 – end.

Market Players

Key players in the global market of scoring balloon catheter are

  • B. Braun Melsungen AG
  • Medtronic Plc
  • Tokai Medical Products Inc.
  • BIOTRONIK SE & Co. KG
  • Terumo Corporation
  • Boston Scientific Corporation
  • Jotech GmbH
  • MicroPort Scientific Corporation
  • Hexacath
  • Meril Life Sciences Pvt Ltd
  • Cordis Corporation
  • Abbott Laboratories

Explore Fact.MR’s Coverage on the Healthcare Domain

Implantable Pump Catheter Market: A recent study by Fact.MR on the Implantable Pump Catheter Market offers a 10-year forecast analysis for the period 2021 to 2031. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Coronary Microcatheters Market: Fact.MR’s extensive coverage on the Coronary Microcatheters Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Chronic Total Occlusion Catheter Market: The Chronic Total Occlusion Catheter Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlook. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Research Insight: https://www.factmr.com/report/148/scoring-balloon-catheter-market
Content Source: 
https://www.factmr.com/media-release/137/scoring-balloon-catheter-market

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

By using this website you agree to accept Medical Device News Magazine Privacy Policy